V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008513 | 10005208 | 1.77 | 93 | Palliative (P) | 2013-09-02 | 2013-09-10 | Mereletinib | N | N | 10537685 | CISPLATIN + GEMCITABINE |
| 10008514 | 10005209 | 1.5 | 85.7 | Palliative (P) | 2013-12-24 | 2014-01-03 | NIVOLUMAB | null | Y | 10537747 | IMATINIB |
| 10008515 | 10005211 | 1.56 | 69.4 | Palliative (P) | 2017-05-06 | 2017-05-06 | MELPHALAN | N | Y | 10538200 | CYCLO + DOCETAXEL + TRASTUZUMAB |
| 10008516 | 10005213 | 1.67 | 68.4 | Palliative (P) | 2018-06-14 | 2018-06-21 | EC | 2 | N | 10538612 | ATG + BUSULFAN + FLUDARABINE |
| 10008517 | 10007603 | null | null | Adjuvant (A) | 2017-08-18 | 2017-08-30 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | N | N | 10538869 | CETUXIMAB |
| 10008518 | 10005221 | 1.75 | 79.6 | Not known (9) | 2018-05-10 | 2018-05-10 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 01 | N | 10539671 | PAZOPANIB |
| 10008519 | 10005228 | 1.72 | 70.5 | Radical (R) | 2015-12-08 | 2016-01-02 | AML18 PILOT TRIAL | 02 | N | 10541003 | AFATINIB |
| 10008520 | 10005231 | null | 135.5 | Curative (C) | 2018-08-23 | 2018-10-18 | Dacarbazine | 2 | N | 10541130 | PACLITAXEL + RAMUCIRUMAB |
| 10008521 | 10007606 | 1.74 | 70.6 | null | 2016-03-11 | 2017-04-22 | Docetaxel + Nintedanib | 02 | N | 10541154 | NIVOLUMAB |
| 10008522 | 10005237 | 1.8 | 104.7 | Palliative (P) | 2015-09-05 | 2016-11-23 | CAV | 02 | Y | 10541907 | CETUXIMAB + IRINOTECAN + MDG |
| 10008523 | 10005239 | 1.71 | 52.7 | Curative (C) | 2018-03-22 | 2018-06-14 | CISPLATIN + VINORELBINE + RT | N | N | 10542182 | ENZALUTAMIDE |
| 10008524 | 10007610 | 1.7 | null | Disease modification (D) | null | 2018-10-26 | Cytarabine HD + Rituximab | 02 | N | 10542282 | VINORELBINE |
| 10008525 | 10007611 | 1.76 | 80 | Curative (C) | 2018-12-11 | 2019-01-09 | Brentuximab | 02 | N | 10542373 | CARBO + FLUOROURACIL |
| 10008526 | 10005244 | 1.77 | 90 | Palliative (P) | 2017-11-19 | 2017-12-12 | NIVOLUMAB | N | N | 10542654 | METHOTREXATE |
| 10008527 | 10005246 | 1.7 | 91.6 | Adjuvant (A) | 2019-01-21 | 2019-02-03 | Melphalan IV High dose | 2 | N | 10542683 | CETUXIMAB + IRINOTECAN + MDG |
| 10008528 | 10005248 | 1.62 | 80 | Palliative (P) | 2018-02-09 | 2018-02-12 | NIVOLUMAB | N | N | 10543189 | CAPECITABINE + RT |
| 10008529 | 10005249 | 1.64 | 56.6 | Disease modification (D) | 2016-12-17 | 2017-02-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | 10543551 | PERTUZUMAB + TRASTUZUMAB |
| 10008530 | 10005251 | 1.79 | null | Not known (9) | 2017-08-31 | 2017-09-04 | Cetuximab + Radiotherapy Maint | 02 | N | 10543662 | NIVOLUMAB |
| 10008531 | 10005253 | 0 | 85.7 | Adjuvant (A) | 2019-07-14 | 2019-07-21 | IPILIMUMAB + NIVOLUMAB | 02 | N | 10543801 | CLADRIBINE |
| 10008532 | 10005255 | 1.89 | 65.2 | Palliative (P) | 2018-02-09 | 2018-02-21 | CAP + RT | 02 | N | 10543951 | IRINOTECAN |
| 10008533 | 10005256 | 1.57 | 69.5 | Palliative (P) | 2018-02-17 | 2018-02-19 | Chlorambucil | N | N | 10544006 | CISPLATIN + VINORELBINE |
| 10008534 | 10005258 | 1.82 | 88.65 | Palliative (P) | 2017-07-18 | 2017-07-29 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 10544017 | CETUXIMAB |
| 10008535 | 10005259 | 1.66 | 74.5 | Palliative (P) | 2014-02-25 | 2014-02-26 | STAMPEDE TRIAL | null | null | 10544223 | DASATINIB |
| 10008536 | 10005259 | 1.64 | null | Palliative (P) | 2014-06-17 | 2014-09-10 | BUSULFAN | N | N | 10544223 | MELPHALAN |
| 10008537 | 10005261 | 1.65 | 91 | Palliative (P) | 2016-01-21 | 2016-01-21 | Vinblastine | 02 | N | 10544323 | R-EPOCH |
| 10008538 | 10005264 | 1.74 | 65.3 | Palliative (P) | 2019-02-18 | 2019-03-05 | CRIZOTINIB | N | N | 10544570 | EC |
| 10008539 | 10005267 | 1.79 | 95.6 | Palliative (P) | 2016-02-08 | 2016-02-29 | FLAIR Trial | N | N | 10544598 | CARBOPLATIN + RT |
| 10008540 | 10005274 | null | null | Adjuvant (A) | 2018-04-20 | 2018-04-20 | Busulfan Oral | N | N | 10545093 | ECX |
| 10008541 | 10005276 | null | 80 | Adjuvant (A) | 2017-12-23 | 2017-12-23 | Enzalutamide | N | N | 10545551 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10008542 | 10005278 | 1.74 | 73.1 | Palliative (P) | 2018-08-20 | 2018-08-21 | PMitCEBO | 02 | N | 10545602 | GDP |
| 10008543 | 10005281 | 1.76 | 100.6 | null | 2015-01-02 | 2015-10-08 | PROCAID TRIAL | N | N | 10545673 | MELPHALAN |
| 10008544 | 10005283 | 1.78 | 75.2 | Disease modification (D) | 2015-12-04 | 2015-12-04 | CAPECITABINE + RT | N | N | 10545700 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 10008545 | 10007628 | 1.85 | 110.15 | Palliative (P) | 2018-04-07 | 2019-03-26 | Cisplatin + Radiotherapy | N | N | 10545781 | VINCRISTINE |
| 10008546 | 10005285 | null | null | Curative (C) | 2016-06-25 | 2016-11-01 | CARBOPLATIN + RT | N | Y | 10545782 | ABVD |
| 10008547 | 10005285 | 1.63 | 68.6 | null | 2018-08-06 | 2018-08-06 | Carboplatin + Liposomal Doxorubicin | N | N | 10545782 | IPILIMUMAB |
| 10008548 | 10005287 | 1.66 | 57.38 | Adjuvant (A) | 2017-09-09 | 2017-09-28 | Cisplatin + Pemetrexed | N | N | 10545974 | FEC + DOCETAXEL + TRASTUZUMAB |
| 10008549 | 10005292 | 1.76 | 73.1 | Disease modification (D) | null | 2014-12-18 | Fluorouracil+Mitomycin+RT (Bladder) | 2 | N | 10546378 | AFATINIB |
| 10008550 | 10005293 | 1.67 | null | Palliative (P) | 2017-10-19 | 2017-10-29 | CAPECITABINE + IRINOTECAN | N | N | 10546381 | ARSENIC TRIOXIDE + TRETINOIN |
| 10008551 | 10005294 | 1.61 | 62.2 | null | null | 2018-12-08 | Cyclophosphamide oral | N | Y | 10546510 | PANITUMUMAB |
| 10008552 | 10005296 | null | null | Not known (9) | 2018-06-12 | 2018-06-13 | CISPLATIN + VINORELBINE | null | N | 10546566 | CISPLATIN + PEMETREXED |
| 10008553 | 10005298 | 1.6 | 42.7 | Adjuvant (A) | 2018-07-23 | 2018-08-19 | Cisplatin + Doxorubicin | 2 | Y | 10546671 | FEC |
| 10008554 | 10007637 | 1.79 | 82.3 | Disease modification (D) | 2014-05-01 | 2014-06-06 | LEAM | 02 | N | 10546808 | TRIFLURIDINE + TIPIRACIL |
| 10008555 | 10005304 | null | 88.5 | Palliative (P) | 2018-05-18 | 2018-09-12 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 10547111 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 10008556 | 10007638 | 1.52 | 56.4 | Palliative (P) | 2015-02-28 | 2015-03-14 | Capecitabine (14 day) + Irinotecan | 2 | Y | 10547404 | CETUXIMAB + IRINOTECAN + MDG |
| 10008557 | 10005308 | 1.62 | 91 | Curative (C) | 2017-03-13 | 2017-03-20 | Cytarabine HD + Rituximab | 02 | N | 10547784 | CABOZANTINIB |
| 10008558 | 10007641 | null | 73.1 | Adjuvant (A) | null | 2018-11-06 | Hydroxycarbamide | N | N | 10548704 | BORTEZOMIB + PANOBINOSTAT |
| 10008559 | 10005314 | 0 | null | Curative (C) | 2015-04-06 | 2015-05-17 | Bortezomib (weekly) | N | N | 10548786 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10008560 | 10007643 | 1.52 | 87 | null | 2017-08-10 | 2017-09-19 | CAPECITABINE + IRINOTECAN | 02 | N | 10548978 | BRENTUXIMAB |
| 10008561 | 10005319 | 1.58 | 76.2 | Palliative (P) | 2015-11-18 | 2015-11-25 | OSIMERTINIB | N | N | 10548979 | CHLORAMBUCIL + RITUXIMAB |
| 10008562 | 10005321 | 1.86 | 51 | null | 2018-02-16 | 2018-10-13 | Bortezomib +/- Dexamethasone | 2 | Y | 10549181 | CYTARABINE HIGH DOSE |